NEW YORK, September 15, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: KBR Inc. (NYSE: KBR), AECOM (NYSE:ACM), Jacobs
Engineering Group Inc. (NYSE: JEC), Qiagen N.V. (NASDAQ: QGEN), and
Myriad Genetics Inc. (NASDAQ: MYGN). Free research report on KBR
Inc. can be accessed at
https://www.erionline.net/reports?keyword=KBR On Monday, September 14, 2015, the NASDAQ Composite
ended at 4,805.76, down 0.34%, the Dow Jones Industrial Average
edged 0.38% lower, to finish the day at 16,370.96, and the S&P
500 closed at 1,953.03, down 0.41%. The losses were broad based as
eight out of nine sectors ended the session in negative. Register
for your complimentary reports at the links given below.
KBR Inc.'s stock edged 0.06% higher, to close the day at
$17.04. The stock recorded a trading
volume of 1.23 million shares, below its three months average
volume of 1.59 million shares. Over the last one month and over the
past three months, KBR Inc.'s shares have declined 7.60% and
13.18%, respectively. However, the stock has advanced 1.95% since
the start of this year. The company's shares are trading 0.25%
below their 200-day moving average. Additionally, KBR Inc. has a
Relative Strength Index (RSI) of 46.54. Sign up and read the free
notes on KBR at:
https://www.erionline.net/reports?keyword=KBR
On Monday, shares in AECOM recorded a trading volume of 1.38
million shares, below their three months average volume of 1.49
million shares. The stock ended the day 0.84% lower at $27.06. AECOM's stock has plummeted 6.59% in the
last one month, 18.30% in the previous three months and 10.90% on
YTD basis. The company is trading below its 50-day and 200-day
moving averages by 8.27% and 11.09%, respectively. Furthermore,
shares of AECOM have an RSI of 41.66. The complimentary notes on
ACM can be downloaded in PDF format at:
https://www.erionline.net/reports?keyword=ACM
Jacobs Engineering Group Inc.'s stock lost 2.34%, to close
Monday's session at $39.25. The stock
recorded a trading volume of 1.60 million shares, above its three
months average volume of 1.46 million shares. Over the last one
month and the previous three months, Jacobs Engineering Group
Inc.'s shares have declined 10.37% and 7.21%, respectively.
Additionally, the stock has lost 12.17% since the start of this
year. The company is trading 4.42% and 8.44% below its 50-day and
200-day moving averages, respectively. Furthermore, Jacobs
Engineering Group Inc.'s stock traded at a PE ratio of 14.02 and
has an RSI of 43.30. Register for free on Equity Research Institute
and access the latest research on JEC at:
https://www.erionline.net/reports?keyword=JEC
Qiagen N.V.'s stock finished Monday's session 0.07% higher at
$26.70. A total of 0.49 million
shares were traded, which was below its three months average volume
of 0.82 million shares. Over the past three months and since the
beginning of 2015, Qiagen N.V.'s shares have gained 9.16% and
13.81%, respectively. However, the stock has lost 3.40% in the last
one month. The company's shares are trading above their 200-day
moving average by 7.18%. Qiagen N.V.'s stock traded at a PE ratio
of 60.68 and has an RSI of 50.90. The complete research on QGEN is
available for free at:
https://www.erionline.net/reports?keyword=QGEN
On Monday, shares in Myriad Genetics Inc. ended the session
2.11% higher at $39.27. The stock
reported a trading volume of 1.04 million shares, above its three
months average volume of 0.78 million shares. Shares of the company
traded at a PE ratio of 36.03. Myriad Genetics Inc.'s shares have
surged 15.77% in the last one month, 24.55% in the previous three
months and 15.30% on YTD basis. The company is trading 13.78% above
its 50-day moving average and 12.97% above its 200-day moving
average. Moreover, shares of Myriad Genetics Inc. have an RSI of
64.58. Free in-depth research on MYGN is available at:
https://www.erionline.net/reports?keyword=MYGN
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"),
provides necessary guidance in preparing the document templates.
The Reviewer has reviewed and revised the content, as necessary,
based on sound investment judgment and publicly available
information which is believed to be reliable. The Reviewer and the
CFA® have not performed any independent investigations or forensic
audits to validate the information herein. Unless otherwise noted,
any content outside of this document has no association with the
Author, the Reviewer, or the CFA® (collectively referred to as the
"Production Team") in any way. The Production Team is compensated
on a fixed monthly basis and do not hold any positions of interest
in any of the securities mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the CFA® (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.erionline.net.
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia. Do not send email to
robottrap (at) erionline.net.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.erionline.net